Ligand Pharmaceuticals Director John W. Kozarich Reports Sale of Common Shares
John W. Kozarich, Director at Ligand Pharmaceuticals Inc., has reported the sale of common shares of the company, as per a recent SEC filing. This information was disclosed through EDGAR, the SEC's Electronic Data Gathering, Analysis, and Retrieval system. The original content was published by Ligand Pharmaceuticals Inc. on December 03, 2025.
John W. Kozarich, Director at Ligand Pharmaceuticals Inc., reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-25-000113), on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
